Characteristics of Thrombin-Degranulated Human Platelets: Development of a Method that Does not Use Proteolytic Enzymes for Deaggregation

Summary

A method has been developed for preparing suspensions of washed human platelets that have lost as much as 90% of their dense granule and alpha granule contents as a result of stimulation by thrombin (0.9 U/ml for 3 min at 37° C), and recovering the platelets without using a proteolytic erwyme. Glycyl-Lprolyl-Larginyl-L-proline (GPRP) was used to prevent polymerization of released fibrinogen and arginyl-glycyl-aspartyl-serine (RGDS) to block the interaction of released fibrinogen, vWf or fibronectin with the glycoprotein IIb/IIIa complex. The thrombin used to degranulate the platelets was neutralized with D-phenylalanyl-Lprolyl-L-arginine chlororhethyl ketone (FPRCH₂CI) and prostaglandin E₁ was added to return the platelets towards a disc shape. The degranulated platelets aggregated in response to ADR platelet activating factor, arachidonate and the thromboxane 42 mimetic, U46619 in the presence of added fibrinogen; the platelets changed shape but did not aggregate in response to collagen. Thrombin and the calcium ionophore, A23L87, caused aggregation without added fibrinogen. Synergism between pairs of aggregating agents at low concentrations was observed. Little TXB₂ was formed when the platelets were reaggregated by thrombin. RGDS and F(ab’)₂ fragments of an antibody to fibrinogen inhibited reaggregation induced by thrombin and A23187 indicating that small amounts of fibrinogen at the platelet surface may support aggregation by strong agonists. Adherence of thrombin-degranulated platelets to a collagen-coated surface was less than for controls, but spreading was more extensive. Electron-microscopic immunogold cytochemistry with anti-human fibrinogen IgG showed numerous gold particles in platelet vacuoles. Thrombin-degranulated platelets can be used to study pathways involved in platelet aggregation without the complicating effects of released granule contents including ADR and to study indirectly the factors released from platelets that contribute to the stability of platelet aggregates.

• References

• 1 Reimers H-J, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol 1973; 25: 675-689
• 2 Kinlough-Rathbone RL, Chahil A, Packham MA, Reimers H-J. Mustard JE Effect of A23,187 on thrombin-degranulated washed rabbit platelets. Thromb Res 1975; 7: 435-449
• 3 Reimers H-J, Kinlough-Rathbone RL, Cazenave J-R, Senyi AR, Hirsh J, Packham MA, Mustard JE. In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemostas 1976; 35: 151-166
• 4 Kinlough-Rathbone RL, Reimers H-J, Mustard JS, Packham MA. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science 1976; 192: 1011-1012
• 5 Guccione MA, Kinlough-Rathbone RL, Packham MA, Harfenist EJ, Rand ML, Greenberg JP, Perry DW, Mustard JE. Effects of plasmin on rabbit platelets. Thromb Haemostas 1985; 53: 8-14
• 6 Greenberg JR, Packham MA, Guccione MA, Rand ML, Reimers H-J, Mustard JE. Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin or neuraminidase. Blood 1979; 53: 916-927
• 7 Harfenist EJ, Guccione MA, Packham MA, Mustard JE. The use of the synthetic peptide, Gly-Pro-Arg-Pro, in the preparation of thrombin-degranulated rabbit platelets. Blood 1982; 59: 952-955
• 8 Laudano AP, Doolittle RE. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerrzation of fibrin monomers. Proc Natl Acad Sci (USA) 1978; 75: 3085-3089
• 9 Laudano AP, Doolittle RE. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19: 1013-1019
• 10 Kinlough-Rathbone RL, Mustard JF, Perry DW, Dejana E, Cazenave J-P, Packham MA, Harfenist EJ. Factors influencing the deaggregation of human and rabbit platelets. Thromb Haemostas 1983; 49: 162-167
• 11 Kinlough-Rathbone RL, Perry DW, Packham MA, Mustard JE. Deaggregation of human platelets aggregated by thrombin. Thromb Haemostas 1985; 53: 42-44
• 12 Molnar J, Lorand L. Studies on apyrases. Arch Biochem Biophys 1961; 93: 353-363
• 13 Mustard JR, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228: 1757-1765
• 14 Cazenave J-P, Packham MA, Mustard JE. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med 1973; 82: 978-990
• 15 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br. J Haematol 1972; 22: 193-204
• 16 Kinlough-Rathbone RL, Packham MA, Mustard JE. Platelet aggregation. In: Methods in Hematology Measurements of Platelet Function. Harker LA, Zimmerman TS. eds Churchill Livingstone; Edinburgh: 1983: 64-91
• 17 Cazenave J-R, Blondowska D, Richardson M, Kinlough-Rathbone RL, Packham MA, Mustard JE. Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to collagen-coated surface and to subendothelium with a rotating probe device. J Lab Clin Med 1979; 93: 60-70
• 18 Suzuki H, Kinlough-Rathbone RL, Packham MA, Thnoue K, Yamazaki H, Mustard JE. Immunocytochemical localtzation of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine-diphosphate induced responses and enhanced fibrinogen binding in a medium with low calcium levels Blood 1988; 71: 850-860
• 19 Danscher G, Ntirgaard JOR. Light microscopic visualization of colloidal gold on resin-embedded tissue. J Histochem Cytochem 1983; 31: 1394-1398
• 20 Reimers HJ, Scharf RE, Baker RK. Thrombin pretreatment of human platelets impairs thromboxane A₂ synthesis from endogenous precursors in the presence of norrral cyclo-oxygenase activity. Blood 1984; 63: 858-865
• 21 Stockschlaider M, Scharf R. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma. Thromb Haemostas 1989; 62: 1016-1022
• 22 Bauman JE, Reimers HJ, Joist JH. Deaggregation of in vitrodegranulated human platelets: irreversibility of aggregation may be agonist-specific rather than related to secretion per se. Thromb Haemostas 1987; 58: 899-904
• 23 Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham MA, Mustard JE. Fibrinogen-independent aggregation and deaggregation of human platelets; studies in two afibrinogenemic patients. Blood 1987; 70: 221-226
• 24 Wencel-Drake JD, Plow ER, Kunicki TI, Woods IL, Keller DM, Ginsberg MH. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986; 124: 324-334
• 25 Wencel-Drake J. Plasma membrane GPIIbAIIa. Evidence for a cycling receptor pool. Am J Pathol 1990; 136: 61-70
• 26 Legrand C, Dubernard V, Nurden AL. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood 1989; 73: 1226-1234
• 27 Watts IS, Keery RI, Lumley P. Differential ability of agonists to express distinct pools of fibrinogen (GPIIb/IIIa) receptors which can mediate the aggregation of human platelets. Thromb Haemostas 1989; 62: 955-961
• 28 Peerschke EIB, Wainer JA. Examination of irreversible plateletfibrinogen interactions. Am J Physiol 1985; 248: 146-172
• 29 Peerschke EIB. Irreversible platelet fibrinogen interactions occur independently of fibrinogen alpha chain degradation and are not mediated by intact platelet membrane glycoprotein II b/III a complexes. J Lab Clin Med 1988; 111: 84-92
• 30 Kinlough-Rathbone RL, Packham MA, Mustard JE. Synergism between platelet aggregating agents; the role of the arachidonate pathway. Thromb Res 1977; 11: 567-580
• 31 Kinlough-Rathbone RL, Mustard JE. Synergism of agonists. In: Platelet Responses and Metabolism Vol. 1. Responses Holmsen H. ed CRC Press; Boca Raton, FL: 1986: 193-207
• 32 Scharf RE. Acquired platelet storage pool deficiency: clinical and experimental considerations (Alexander Schmidt Memorial Lecture). In: Rational Diagnosis and Tleatment of Haemorrhagic Diathesis and Thromboembolic Disorders Wenzel E, Hellstern P, Morgenstern E, Kcihler M, von Blohn G. eds Stuttgart: E K; Schattauer Verlag: 1986: 1.27-1.44
• 33 Stuart MJ, Kelton J, Allen JB. Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. Blood 1981; 58: 326-329
• 34 Capitanio A, Mannucci PM, Ponticelli C, Pareti E. Detection of circulating released platelets after renal transplantation. Tlansplantation 1982; 33: 298-301
• 35 Remuzzi G, Benigni A, Dodesini R, Schieppati A, Livio M, de Gaetano G, Day JS, Smith WL, Pinca E, Patrignani P, Patrono C. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclo-oxygenase defect. J Clin Invest 1983; 7l: 762-768
• 36 Smith JB, Ingerman CM, Silver MJ. Prostaglandins and precursors in platelet function. In: Biochemistry and Pharmacology of Platelets, Ciba Foundation Symposium 35 (New Series) Elsevier/Excerpta Medica/North-Holland; New York: 1975: 207-224
• 37 Packham MA, Kinlough-Rathbone RL, Mustard JE. Thromboxane A₂ causes feedback amplification involving extensive thromboxane A₂ formation on close contact of human platelets in media with a low concentration of ionized calcium. Blood 1987; 70: 647-51
• 38 Willems C, DeGroot PG, Pool GA, Gonsalvez MS, Van Aken WG, Van Mourik JA. Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetyl salicylic acid. Biochim Biophys Acta 1982 713. 581-588
• 39 Vickers JD, Mustard JE. The phosphoinositides exist in multiple metabolic pools in rabbit platelets. Biochem J 1986; 238: 411-7
• 40 Prescott SM, Majerus PW. The fatty acid composition of phosphatidyl inositol from thrombin-stimulated human platelets. J Biol Chem 1981; 256: 579-582
• 41 Imai A, Yano K, Kameyama Y, Nozawa Y. Reversible thrombininduced modification of positional distribution of fatty acids in platelet phospholipids: involvement of deacylation-reacylation. Biochem Biophys Res Commun 1981; 103: 1092-1099
• 42 Nurden AI. Glycoprotein defects responsible for abnormal platelet function in inherited platelet disorders. In: Platelet Membrane Glycoproteins George JN, Nurden AI, Phillips DR. eds Plenum Press; NY: 1985: 357-392
• 43 Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in cit rated and native blood. I. Shear-dependent decrease of adhesion in von Willebrand’s disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978 92. 750-764